1Nguyen NP, Sallah S, Karlsson U, et al. Combined preoperative chemotherapy and radiation for locally advanced rectal carcinoma.Am J Clin Oncol,2000,23 (5) :442-448.
2Grann A, Feng C, Wong D, et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys,2001,49 (4):987-995.
3Rullier E, Goffre B, Bonnel C, et al. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg,2001,234 (5) :633-640.
5Movsas B, Hanlon AL, Lanciano R, et al. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys, 1998, 42(1):43-50.
6Myerson RJ, Valentini V, Bimbaum EH, et al. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma. Int J Radiat Oneol Biol Phys, 2001,50(5) : 1299-1308.
7Mehta VK, Cho C, Ford JM, et al. Phase II trial of preoperative 3D eonformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys, 2003,55 ( 1 ) : 132-137.
8Freyer G, I3ossard N, Romestakn4g P, et al. Addition of oxaliplatin to continuous fluorouracil, 1-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial. J Clin Oncol,2001,19 (9) : 2433-2438.
9Gerard JP, Chapet O, Nernoz C, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-eontaining regimen: the Lyon R0-04 phase II trial. J Clin Oncol, 2003, 21 (6):1119-1124.
10Carraro S, Roca EL, Cartelli C, et al. Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leueovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study. Int J Radiat Oneol Biol Phys, 2002,54 (2): 397-402.
